- Home
- NSLR vs HUMA Comparison
NSLR vs HUMA Comparison
Compare NSLR & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NSLR | HUMA |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 180.3M | 165.7M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NSLR | HUMA |
|---|---|---|
| Price | $6.13 | $0.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $14.15 | $1.63 |
| AVG Volume (30 Days) | 284.7K | ★ 5.7M |
| Earning Date | 11-03-2026 | 11-10-2026 |
| Dividend Yield | ★ 17.36% | N/A |
| EPS Growth | N/A | ★ 79.37 |
| EPS | ★ 3.89 | N/A |
| Revenue | N/A | ★ $2,038,000.00 |
| Revenue This Year | N/A | $72.32 |
| Revenue Next Year | $14.90 | $518.79 |
| P/E Ratio | $1.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.46 | $0.34 |
| 52 Week High | $12.19 | $1.53 |
Technical Indicators
Market Signals| Indicator | NSLR | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 41.61 | 50.41 |
| Support Level | $5.72 | $0.36 |
| Resistance Level | $8.36 | $0.48 |
| Average True Range (ATR) | 0.31 | 0.05 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 72.97 | 54.56 |
Price Performance
Historical ComparisonAbout NSLR Neostellar Capital Corp. Common Stock
Neostellar Capital Corp is an investment company focused on private, venture-backed businesses. It invests in companies that are not yet listed on a public stock exchange. It helps investors to gain exposure to a portfolio of VC-backed companies through a publicly traded stock.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.